Table 1

Baseline characteristics of the patients included in the SVASONA trial

Programmable valve group (n=71)Gravitational valve group (n=74)
Sex
 Male (n (%))48 (68)41 (55)
 Female (n (%))23 (32)33 (45)
Age at surgery (years) (mean (SD))71.2 (7.0)72.7 (6.7)
BMI (mean (SD))28.6 (4.2)27.1 (4.1)
Evans Index (mean (SD))0.38 (0.06)0.37 (0.05)
Cortical atrophy, any grade (n (%))61 (86)67 (91)
Mean intracranial pressure (mm H2O) (mean (SD))9.6 (3.6)9.6 (3.1)
ASA III patients (n (%))23 (32)25 (34)
Charlson Comorbidity Index (n)
 Not indicated87
 01824
 12020
 2911
 377
 475
 >420
Duration of surgery (min) (mean (SD))60.5 (22.5)61.9 (23.7)
Duration of hospital stay (days) (mean (SD))7.9 (4.3)7.1 (3.9)
Gravitational unit opening pressure (mm H2O) (n)
 20020
 25034
 30016
 3504
Postoperative CT scan (n (%))70 (99)71 (96)
Interval to postoperative CT (days) (mean (SD))3.9 (3.7)4.2 (4.5)
  • ASA, American Society of Anaesthesiologists physical status classification system; BMI, body mass index; SVASONA trial, Shunt Valves plus shunt Assistant versus Shunt valves alone for controlling Overdrainage in idiopathic Normal pressure hydrocephalus in Adults trial.